 |
HPV Vaccination
|
 |
Population-level effectiveness of HPV vaccination: impact of herd immunity
Marc Brisson, PhD [Bio]
Canada Research Chair in Mathematical Modeling and Health Economics of Infectious Disease
Social and preventive Medicine, Université Laval
|
 |
Therapeutic Vaccines for Chronic Infection and Cancer:
Barriers and Hopes
W. Martin Kast, PhD [Bio]
Walter A. Richter Cancer Research Chair
Professor of Molecular Microbiology & Immunology and Obstetrics & Gynecology
Norris Comprehensive Cancer Center (NRT 7507)
University of Southern California
|
 |
Evaluation of HPV Vaccination Programs
Mona Saraiya, MD, MPH [Bio]
Medical Epidemiologist
CDC, Division of Cancer Prevention and Control
|
|
HPV Screening
|
 |
New Molecular Markers for Cervical Cancer Screening:
Distinguishing Hype from Hope
Philip E. Castle, PhD, MPH [Bio]
Investigator
National Cancer Institute, National Institutes of Health
|
 |
Are We Ready to Move to HPV Testing for Primary Screening?
Jack Cuzick, PhD [Bio]
John Snow Professor of Epidemiology, Head of Department
Cancer Research UK Centre for Epidemiology, Mathematics and Statistics
Queen Mary, University of London
Wolfson Institute of Preventive Medicine
|
 |
Cervical Cancer Screening in Developing Countries
Rengaswamy Sankaranarayanan, MD [Bio]
Chief of the Cancer Screening Group
International Agency for Research on Cancer
Lyon, France
|
|
Natural History and Extragenital Infections
|
 |
The Biology of HPV-associated Disease
John Doorbar, PhD [Bio]
Group Leader, Division of Virology
National Institute for Medical Research
London, UK
|
 |
Current Knowledge and Gaps about HPV Natural History
Denise A. Galloway, PhD [Bio]
Head, Cancer Biology Program
Member, Human Biology and Public Health Sciences Divisions
Fred Hutchinson Cancer Research Center
|
 |
Molecular Basis of PV Oncogenecity
Magnus von Knebel Doeberitz, MD [Bio]
Department of Applied Tumor Biology
Institute of Pathology
University of Heidelberg
|
|
Advocacy and Sexual Health Issues
|
 |
Sexual Behaviour, HPV Infection and Related Diseases
Ann N. Burchell, PhD [Bio]
Division of Cancer Epidemiology
Departments of Oncology and Epidemiology and Biostatistics
McGill University, Montreal, Canada
|
 |
HPV Modeling
Shalini L. Kulasingam, PhD [Bio]
Assistant Professor, Department of Epidemology and Community Health, University of Minnesota School of Public Health, Minneapolis, MN, USA
|
 |
Psychosocial Effects of Screening
Gregory D. Zimet, PhD [Bio]
Professor of Pediatrics & Clinical Psychology
Section of Adolescent Medicine
Indiana University School of Medicine
Health Information & Translational Sciences
|
|
